What is the primary purpose of this $1.6 billion note issuance?

The primary purpose is to refinance existing debt. HCA intends to use the net proceeds to redeem its outstanding $1.525 billion aggregate principal amount of 7 3/4% Senior Notes due 2021, with any remaining funds allocated for general corporate purposes.

How does this new debt offering impact HCA's existing debt structure?

This offering allows HCA to replace higher-interest debt (7.75%) with lower-interest debt (5.375%), which should reduce its overall interest expense. It also extends the maturity profile of a portion of its debt.

What are the key terms of the new 5.375% Senior Notes due 2025?

The notes mature on February 1, 2025, with interest payable semi-annually on February 1 and August 1. They are senior unsecured obligations of HCA Inc., guaranteed by HCA Holdings, Inc., and rank equally with other senior indebtedness but are effectively subordinated to secured debt and structurally subordinated to subsidiary debt.

What protections do investors have in this note offering?

The notes are governed by an Indenture that includes covenants limiting the ability of HCA and its subsidiaries to create liens, engage in sale and lease-back transactions, or dispose of substantially all assets. Additionally, a 'change of control' provision requires HCA to repurchase the notes at 101% of the principal amount plus accrued interest if a specified change of control event occurs.

HCA 8-K: Material Agreements & Financial Events

Summary

This 8-K filing by HCA Healthcare, Inc. (HCA) on May 20, 2015, announces the successful completion of a public offering of $1.6 billion in aggregate principal amount of 5.375% Senior Notes due 2025. These new notes are fungible and will be treated as a single series with previously issued notes of the same series. The primary purpose of this offering is to redeem HCA's outstanding 7 3/4% Senior Notes due 2021, amounting to $1.525 billion, with the remaining proceeds intended for general corporate purposes. This transaction represents a significant refinancing effort by HCA, aiming to reduce its overall interest expense by replacing higher-coupon debt with lower-cost financing. The issuance of these notes demonstrates HCA's continued access to capital markets and its strategy to optimize its debt structure. Investors should note the terms of the new notes, including their maturity, interest rate, ranking, and covenants, as detailed in the filing.

Key Highlights

1HCA completed a public offering of $1.6 billion in 5.375% Senior Notes due 2025.
2The net proceeds of approximately $1.631 billion will be used to redeem $1.525 billion of 7 3/4% Senior Notes due 2021.
3The new notes are fungible with previously issued notes of the same series, forming a single larger series.
4The notes are senior unsecured obligations of HCA Inc., guaranteed on a senior unsecured basis by the Parent Guarantor (HCA Holdings, Inc.).
5The Indenture includes covenants restricting liens, sale and lease-back transactions, and asset dispositions.
6A change of control provision allows noteholders to require repurchase at 101% of principal plus accrued interest.
7The filing also details events of default that could lead to acceleration of debt.

HCA Healthcare, Inc. 8-K Report, Material Agreement (May 20, 2015)

Summary

Key Highlights

Frequently Asked Questions